TL;DR:
- Kakao Brain unveils ‘KARA-CXR,’ a web-based radiology report service driven by advanced AI.
- The solution offers two AI interpretations of chest X-ray images: a concise summary and a comprehensive report.
- Users can upload multiple DICOM files simultaneously and share AI interpretations within the medical community.
- Developed in collaboration with 11 leading university hospitals, ‘KARA-CXR’ has analyzed over 16 million chest X-ray images.
- Kakao Brain aims to obtain EU certification and approvals from the US FDA and the Korean Ministry of Food and Drug Safety.
- CEO Kim Il-doo highlights the platform’s potential to streamline radiologists’ workflows and expand beyond chest X-rays to support various medical imaging tests.
- Kakao Brain, founded in 2017, is committed to developing innovative AI technologies to improve quality of life and contributes to the AI community through datasets like ‘Coyo.’
Main AI News:
Kakao Brain proudly presents ‘KARA-CXR,’ a pioneering web-based solution designed for research purposes only (RUO), powered by the cutting-edge “KARA-CXR” algorithm. This innovative AI algorithm revolutionizes the process of generating preliminary radiology reports, providing instant insights for medical professionals upon uploading chest X-ray images to the web.
This user-friendly platform offers an array of functionalities tailored for medical researchers, including the delivery of two distinct AI interpretations of chest X-ray images: a concise summary and a comprehensive full report. Additionally, users can conveniently upload multiple DICOM files simultaneously and receive corresponding reports promptly. Furthermore, researchers can easily share AI interpretations within their research groups or the broader medical community. The platform prioritizes data security, incorporating robust measures to anonymize and safeguard personal information contained in DICOM files.
Development of ‘KARA-CXR’ commenced in 2022 through collaboration with 11 prominent university hospitals and major medical institutions. Notable partners include Ewha Womans University Medical Center, Ajou University Hospital, Soonchunhyang Medical Center, Chungnam National University Hospital, and others. Leveraging a database of over 16 million chest X-ray images and readings, ‘KARA-CXR’ harnesses the power of Kakao Brain’s healthcare-specialized large-scale generative AI model. The research team is poised to disseminate their findings through prestigious academic journals.
Kakao Brain is actively pursuing European Union certification while seeking approval from the US FDA and the Korean Ministry of Food and Drug Safety. Committed to addressing inefficiencies in radiology interpretation and reporting processes, as well as alleviating the burden on healthcare professionals due to radiologist shortages, Kakao Brain envisions expanding the reach of AI-powered radiology solutions. As an RUO tool, KARA-CXR is exclusively available for research purposes and is not intended for diagnostic or treatment use.
Kim Il-doo, CEO of Kakao Brain, affirms the transformative potential of KARA-CXR, emphasizing its role in streamlining radiologists’ workflows and enhancing the efficiency of chest X-ray interpretation. He envisions extending the platform’s capabilities beyond chest X-rays to encompass interactive features supporting various medical imaging tests, leveraging advanced large-scale multi-modal generative AI technology.
Established in 2017, Kakao Brain is a leading global AI technology company headquartered in Korea. Dedicated to developing AI solutions that enrich people’s lives, Kakao Brain embraces innovation and fosters a culture of inquiry. Through groundbreaking technologies like KoGPT, a large-scale language model, and Karlo, an image generation model, Kakao Brain strives to enhance the quality of life through continuous technological advancement. Additionally, Kakao Brain contributes to the AI community by releasing ‘Coyo,’ a vast dataset comprising approximately 740 million images and text, further advancing the frontiers of AI technology.
Conclusion:
Kakao Brain’s launch of ‘KARA-CXR’ signifies a significant advancement in AI-driven radiology solutions. With its user-friendly interface, robust security measures, and potential for expansion into other medical imaging tests, ‘KARA-CXR’ has the potential to revolutionize the radiology market, improving efficiency and accessibility for healthcare professionals worldwide. This move underscores Kakao Brain’s commitment to innovation and its mission to enhance people’s quality of life through transformative AI technology.
